New research published in the July 2025 issue of JNCCN—Journal of the National Comprehensive Cancer Network offers encouraging news for men diagnosed with nonmetastatic prostate cancer.

Novartis shares climb on strong Cosentyx sales, franchise growth, and a new malaria drug approval despite political risks.